|
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS Clinical research trials and A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS. A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS clinical trial. Human subjects often receive the most effective healthcare possible for their A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS  A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS
For Condition: Mycobacterium avium-intracellulare Infection,HIV Infections
Status: Completed
Sponsor(s): Pharmacia ,
Synopsis: To determine if a drug regimen containing rifabutin will eradicate or decrease the numbers of Mycobacterium avium complex (MAC) organisms in blood, improve the symptoms associated with MAC infection, and increase survival in patients with AIDS. To assess the safety of the drug regimen.
Details:
Eligibility:
Study Type: Interventional, Treatment, Double-Blind, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Concurrent Medication: Allowed: - Zidovudine (AZT). - Didanosine (ddI). Patients must have the following: - Diagnosis of AIDS as defined by the CDC. - Blood cultures positive for Mycobacterium avium complex or for acid-fast bacilli (AFB). - Provide written informed consent. Prior Medication: Allowed: - If receiving zidovudine (AZT) or ddI must be taking the medication for at least 4 weeks prior to study entry. - Required: - Antipneumocystis prophylactic therapy for at least 4 weeks prior to study entry. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Known hypersensitivity to any of the study drugs. Concurrent Medication: Excluded: - Other therapy for mycobacterial disease. Patients with the following are excluded: - Known hypersensitivity to any of the study drugs. Prior Medication: Excluded within 4 weeks: - Therapy for mycobacterial disease. - Antiretroviral drugs, other than zidovudine (AZT) or ddI. - Investigational drugs, other than ddI.
Total Enrollment: 200
Location and Contact Information:
AIDS Community Research Consortium
Redwood City, California, 94063
United States
Southwest Community Based AIDS Treatment Group - COMBAT
Los Angeles, California, 90028
United States
Dr Frank Rhame
Minneapolis, Minnesota, 55455
United States
Bay Harbor Hosp
Harbor City, California, 90710
United States
Ctr for Special Immunology
Irvine, California, 92718
United States
Milwaukee County Med Complex
Milwaukee, Wisconsin, 53226
United States
Infectious Disease Physicians Inc
Annandale, Virginia, 22203
United States
San Francisco Veterans Administration Med Ctr
San Francisco, California, 94121
United States
TheraFirst Med Ctrs Inc
Ft. Lauderdale, Florida, 33308
United States
Research Med Ctr
Kansas City, Missouri, 64132
United States
Chelsea Village Med Ctr / Saint Vincent's Hosp
New York City, New York, 10014
United States
North Jersey Community Research Initiative
Newark, New Jersey, 071032842
United States
Maricopa County Med Ctr
Phoenix, Arizona, 85010
United States
Nassau County Med Ctr
East Meadow, New York, 11554
United States
Miami Veterans Administration Med Ctr
Miami, Florida, 33125
United States
HIV Research Group
San Diego, California, 92102
United States
Dr Alfred F Burnside Jr
Columbia, South Carolina, 29204
United States
Ctr for Special Immunology
Ft. Lauderdale, Florida, 33316
United States
Davies Med Ctr
San Francisco, California, 94114
United States
Infectious Disease Research Consortium of Georgia
Atlanta, Georgia, 30076
United States
Veterans Administration Med Ctr
Washington D.C., District of Columbia, 20422
United States
Mem Hosp Hollywood
Hollywood, Florida, 33021
United States
Additional Information:
Study ID Numbers: 048C; CS 087065
Study Start Date:
Record last reviewed: November 1992
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001995
Other Mycobacterium Avium-Intracellulare Infection Studies:
1. Phase II Study of Amithiozone (Thiacetazone) for Patients with Mycobacterium Avium Complex Pulmonary Disease
2. The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
3. A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium avium Infection in HIV-Infected Individuals.
4. A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients
5. A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination with Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
Related Studies:
Other Mycobacterium avium-intracellulare Infection Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-avium Complex (MAC) Bacteremia in Patients With AIDS
|
|
|
|
|
|
|
|
